Zoetis Inc.

About Zoetis Inc. (adapted from Zoetis Inc. prospectus):
Zoetis Inc. discovers, develops, manufactures and commercializes animal health medicines and vaccines, with a focus on both livestock and companion animals. Measured by their revenues of $4.2 billion for the year ended December 31, 2011, Zoetis is the largest animal health medicines and vaccines business, with products sold in more than 120 countries and across eight core species and five major product categories.

Zoetis directly markets their portfolio of more than 300 product lines to livestock producers and veterinarians located in approximately 70 countries across North America, Europe, Africa, Asia, Australia and Latin America. In markets where they do not have a direct commercial presence, they generally contract with distributors that provide logistics and sales and marketing support for their products.

This description is adapted from Zoetis Inc. prospectus. This description is not intended to be a recommendation to buy stock from this company. We do not claim that all of the statements above were researched and found to be true. We present them as a general description based on what the company has said about itself at the time that they submitted their prospectus for an IPO offering. To see the company's full description, view their prospectus..